CMS: journal reprints fall outside of Sunshine exclusion

Share this article:
Marilyn Tavenner
Marilyn Tavenner

It looks like, at least for now, that journal reprints and medical textbooks will remain reportable items under the Sunshine Act.

That was the gist of a response issued by the secretary of the Centers for Medicare and Medicaid Services (CMS) on the medical textbook/journals Sunshine issue.

“We agree that scientific peer-reviewed journal reprints, supplements, and medical textbooks are educational to physicians,” wrote Marilyn Tavenner. “We also appreciate the importance of reprints, supplements, and medical textbooks in potentially improving quality care. However, we do not believe these materials fall within the statutory exclusion.”

Transfers of value in the form of educational materials that directly benefit patients or are intended for patient use may be excluded, Tavenner continued. “Although these items may have downstream benefits for a patient, we believe they are not directly beneficial to patients nor are they intended for patient use…” as required by the statutory exclusion, she noted, quoting the preamble to the final Sunshine rule.

Education materials, such as wall models and anatomical models that are intended to be used with the patient are excluded, she clarified.

That wasn't the answer publishers and agencies were hoping for. In October the Coalition for Healthcare Communication (CHC) had partnered with the American Medical Association (AMA) in an effort to reverse the inclusion of textbooks and reprints in Sunshine Act reporting; 41 medical boards and 32 other physician associations had also joined in.

Nearly two dozen members of Congress sent a letter to CMS to voice disagreement with the HHS decision to include textbooks and reprints as reportable “transfers of value.”

Critics of the policy vowed to fight on. “While the publisher group is disappointed that CMS continues to choose to have texts and journal articles reportable under the Sunshine Act, this decision by CMS flies in the face of letters from organized medicine, industry and Members of Congress,” said John Kamp, CHC executive director.

“Given the CMS stonewall,” Kamp added, “we have no choice but to consider other ways to reverse their decision, including an editorial change to the Sunshine statute or even a court challenge under the First Amendment. Both are now on the table.”

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?